End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.5 EUR | -.--% | -.--% | +3.81% |
2022 | An unknown buyer acquired an unknown minority stake in EQUINOX NEPREMICNINE d.d. from Axor holding d.d. | CI |
2022 | EQUINOX NEPREMICNINE d.d. has completed an IPO. | CI |
Sales 2024 * | 8.71M 9.44M | Sales 2025 * | 8.99M 9.75M | Capitalization | 97.59M 106M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 11.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 10.9 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
4.84% | Yield 2025 * |
4.83% | Free-Float | 36.44% |
1 month | +0.93% | ||
3 months | +4.81% | ||
6 months | +9.00% | ||
Current year | +3.81% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Krivc
CEO | Chief Executive Officer | - | 21-05-02 |
Matej Rigelnik
PRN | Corporate Officer/Principal | - | 21-05-02 |
Tadeja Celar
PRN | Corporate Officer/Principal | - | 21-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Krivc
CEO | Chief Executive Officer | - | 21-05-02 |
Tadeja Celar
PRN | Corporate Officer/Principal | - | 21-05-02 |
Matej Rigelnik
PRN | Corporate Officer/Principal | - | 21-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 54.5 | -.--% | 90 |
24-05-24 | 54.5 | -0.91% | 10 |
End-of-day quote Ljubljana S.E., May 26, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.81% | 106M | |
-10.83% | 26.36B | |
+1.43% | 25.9B | |
+12.29% | 24.19B | |
+35.85% | 21.26B | |
+7.12% | 20.63B | |
-3.28% | 18.43B | |
+3.23% | 16.74B | |
+34.62% | 16.42B | |
+1.04% | 15.04B |
- Stock Market
- Equities
- EQNX Stock